 REHOVOT, Israel and WILMINGTON, Del., March 09, 2022 GLOBE NEWSWIRE -- Ayala Pharmaceuticals, Inc. Nasdaq: AYLA, a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, primarily in genetically defined patient populations, today announced that it will present at the 32nd Annual Oppenheimer Healthcare Conference, taking place on March 15-17, 2022. The company will also participate in one-on-one investor meetings at the conference. 